No photo of Anna Zaniboni

View Scopus Profile

Anna Zaniboni

19962020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Anna Zaniboni is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 39 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Assessment of Duration and Effects of 3 vs 6 Months of Adjuvant Chemotherapy in High-Risk Stage II Colorectal Cancer: A Subgroup Analysis of the TOSCA Randomized Clinical Trial

Petrelli, F., Labianca, R., Zaniboni, A., Lonardi, S., Galli, F., Rulli, E., Rosati, G., Corallo, S., Ronzoni, M., Cardellino, G. G., Mattioli, R., Mambrini, A., Ciuffreda, L., Banzi, M., Pusceddu, V., Maiello, E., Zampino, M., Zagonel, V., Marchetti, P., Corsi, D. & 3 others, Rimassa, L., Cinieri, S. & Sobrero, A., Apr 2020, In : JAMA oncology. 6, 4, p. 547-551 5 p.

Research output: Contribution to journal › Article

    • A systematic review of salvage therapies in refractory metastatic colorectal cancer

    Petrelli, F., Perego, G., Ghidini, A., Ghidini, M., Borgonovo, K., Scolari, C., Nozza, R., Rampulla, V., Costanzo, A., Varricchio, A., Rausa, E., Pietrantonio, F. & Zaniboni, A., May 1 2020, In : International Journal of Colorectal Disease. 35, 5, p. 783-794 12 p.

    Research output: Contribution to journal › Review article

    • Khorana score and thromboembolic risk in stage II–III colorectal cancer patients: a post hoc analysis from the adjuvant TOSCA trial

    Barni, S., Rosati, G., Lonardi, S., Pella, N., Banzi, M., Zampino, M. G., Dotti, K. F., Rimassa, L., Marchetti, P., Maiello, E., Artioli, F., Ferrari, D., Labianca, R., Bidoli, P., Zaniboni, A., Sobrero, A., Iaffaioli, V., De Placido, S., Frassineti, G. L., Ciarlo, A. & 11 others, Buonadonna, A., Silvestris, N., Piazza, E., Pavesi, L., Moroni, M., Clerico, M., Aglietta, M., Giordani, P., Galli, F., Galli, F. & Petrelli, F., Jan 1 2020, In : Therapeutic Advances in Medical Oncology. 12

    Research output: Contribution to journal › Article

    Open Access

    • Neutropenia and survival outcomes in metastatic colorectal cancer patients treated with trifluridine/tipiracil in the RECOURSE and J003 trials

    Yoshino, T., Cleary, J. M., Van Cutsem, E., Mayer, R. J., Ohtsu, A., Shinozaki, E., Falcone, A., Yamazaki, K., Nishina, T., Garcia-Carbonero, R., Komatsu, Y., Baba, H., Argilés, G., Tsuji, A., Sobrero, A., Yamaguchi, K., Peeters, M., Muro, K., Zaniboni, A., Sugimoto, N. & 12 others, Shimada, Y., Tsuji, Y., Hochster, H. S., Moriwaki, T., Tran, B., Esaki, T., Hamada, C., Tanase, T., Benedetti, F., Makris, L., Yamashita, F. & Lenz, H. J., Jan 2020, In : Annals of Oncology. 31, 1, p. 88-95 8 p.

    Research output: Contribution to journal › Article

    Open Access

    • Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial

    GONO Foundation Investigators, Apr 2020, In : The Lancet Oncology. 21, 4, p. 497-507 11 p.

    Research output: Contribution to journal › Article